ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
Published 3 years ago • 90 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
2:20
ev-201: enfortumab vedotin for bladder cancer
-
6:01
ev-201, ev-301 and unite: enfortumab vedotin in advanced urothelial cancer
-
4:15
ev-201: enfortumab an option for cisplatin-ineligible advanced uc | arjun balar
-
1:08
the future of enfortumab vedotin in different stages bladder cancer
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
2:09
enfortumab vedotin for bladder cancer
-
3:07
enfortumab vedotin in urothelial cancer
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
2:52
enfortumab vedotin in urothelial cancer
-
2:09
ev-103: neoadjuvant enfortumab vedotin in cis-ineligible mibc
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
4:16
unite: enfortumab vedotin in advanced urothelial cancer
-
2:43
ev-103: ev with pembrolizumab in cisplatin-ineligible urothelial carcinoma
-
3:24
enfortumab vedotin as treatment for urothelial carcinomas
-
1:09
enfortumab vedotin: targeting bladder cancer
-
0:30
enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
0:35
ev-302: 1l enfortumab vedotin in combination with pembrolizumab
-
2:20
ev-103 cohort k: enfortumab vedotin /- pembro in untreated cis-ineligible patients with muc